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Charles H Spencer1* and Alberto Martini2We are pleased to announce that Pediatric Rheumatology
(PR) has its first impact factor. The journal has just been
given an impact factor of 1.44 this June after 5 years of
association with the online publisher BioMed Central.
This ranks our journal 59th out of 113 pediatric journals
and 22nd out of 29 rheumatology journals and we are
just 5 years old (based on Impact Factor in the 2011 Jour-
nal Citation Reports) [1]. We have been listed on
PubMed since 2007 and have applied for inclusion in
MedLine. These are important steps in the growth and
maturation of our journal. Pediatric Rheumatology is the
only journal entirely devoted to our specialty with an im-
pact factor and as an open access journal can therefore
be reached by medical students, residents, and primary
care physicians and specialists, as well as non-physicians
and the general public all over the world.
We are delighted that the Pediatric Rheumatology
European Society (PReS) has agreed to support this jour-
nal and align its prestigious name and reputation with
us as of January 1, 2013. For the next 5 years the Society
will provide financial support to PR to maintain a com-
petitive price for authors to publish who need assistance-
many authors do not.
Open access journals represent the future of scientific
publications and many University and Research Centers in
the Western world already support their researchers by
covering the costs of publication in these type of journals.
The American National Institutes of Health and the Brit-
ish Wellcome Trust require their grantees to publish open
access within 12 and 6 months respectively, and as the
open access movement gathers momentum [2,3], funding
bodies are faced with the issue of effectively ensuring com-
pliance to these policies [4]. Many Universities support* Correspondence: Charles.Spencer@nationwidechildrens.org
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distribution, and reproduction in any mediumpublication in our Publisher’s journals, with BioMed Cen-
tral Membership accounts providing either a full or partial
discount for their researchers [5]. Moreover, authors from
many low-income countries [6] can publish without
charge. For those authors who do not have the above
mentioned discounts and waivers, publication costs in
open access journals are at present higher with respect to
the other journals because of the lack of subscription fees.
The financial support of PReS will indeed allow competi-
tive publication costs for authors that do not have access
to the above mentioned facilities. As the open access
model is gradually more supported by governments and
granting organizations [7], as appears likely over the next
decade, the financial support of PReS may be needed less.
Meanwhile we hope that our PR journal will become
worthy of many important pediatric rheumatology publi-
cations as the journal grows, and our impact factor
increases. The link between PR and PReS does fit with
one important goal of PReS and all pediatric rheumatol-
ogy organizations. We wish to provide a useful, common
forum for pediatric rheumatologists all over the world
and stimulate the growth of pediatric rheumatology, es-
pecially in growth areas such as Africa and Asia, where
our subspecialty is just beginning to mature. Our open
access model should help interested physicians and
other professionals learn more about our field and the
diseases we care for. Ultimately, we want to do our ut-
most to do what we can to improve medical care for
children with rheumatic and musculoskeletal diseases
everywhere and help each child. Many of us in the West-
ern World come from relatively privileged circumstances.
We at PR believe it is our duty and responsibility to do
what we can for every child with JIA, lupus, dermato-
myositis, and other rheumatic diseases, no matter what
their status and situation. We hope this effort to support
PR will in turn help these children we care about. Recent
educational efforts of PReS, such as our Mumbai, IndiaCentral Ltd. This is an Open Access article distributed under the terms of the
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spread the gospel of pediatric rheumatology.
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